Skip to content
Medical Health Aged Care

Estée Lauder Announces Dr. Matthew Walker as Brand’s First-Ever Global Sleep Science Advisor

Estée Lauder 3 mins read
NEW YORK--BUSINESS WIRE--

Estée Lauder today announces that it has signed Dr. Matthew Walker, PhD, as the brand’s first-ever Global Sleep Science Advisor, leveraging his expertise to deepen Estée Lauder’s nighttime skincare research and innovation, while tapping into the global sleep movement to educate consumers on the vital connection between sleep and health.

A renowned author, sleep scientist and Professor of Neuroscience and Psychology at the University of California, Berkeley, Dr. Walker will bring the latest insights, research findings, and resources to advance Estée Lauder’s ongoing work in understanding and resolving the impact of poor sleep on skin health.

“My mission is to educate as many people as possible on the fundamental importance of sleep for our overall health,” said Dr. Walker. “I’m thrilled to partner with Estée Lauder, a brand that is grounded in science, to educate their consumers around the world on the impact of sleep on mind, body and skin.”

“For more than 40 years, Estée Lauder has been pioneering research into night skin science, most recently focusing on the impact that poor sleep has on skin,” said Jennifer Palmer, Senior Vice President, Global Innovation Development & Science Leadership, Estée Lauder. “By partnering with Dr. Walker, a renowned global sleep expert, we are able to deepen this understanding to inform how we engage, educate and inspire our consumers.”

Dr. Walker will be leveraged for both internal and external events, press opportunities and educational content across brand channels. Estée Lauder will also serve as the exclusive beauty partner of Dr. Walker’s new Global Sleep Education Foundation, which aims to address the global sleep-loss epidemic through free transformational education programs as well as support breakthrough sleep science research.

ABOUT ESTÉE LAUDER
Estée Lauder is the flagship brand of The Estée Lauder Companies Inc. Founded by Estée Lauder, one of the world’s first female entrepreneurs, the brand today continues her legacy of creating the most innovative, sophisticated, high-performance skincare and makeup products and iconic fragrances – all infused with a deep understanding of women’s needs and desires. Today, Estée Lauder engages with consumers in over 150 countries around the world and at dozens of touch points – from in-store to digital. And each of these relationships consistently reflects Estée’s powerful and authentic point of view.

ABOUT DR. MATTHEW WALKER
Matthew Walker, Ph.D., is a professor of neuroscience at the University of California, Berkeley. Walker is the author of The New York Times and international bestseller Why We Sleep: Unlocking the Power of Sleep and Dreams, which was recently listed by Bill Gates as one of his top five books of the year. Matt Walker’s TED Talk, “Sleep is Your Superpower,” has garnered more than 20 million views. He has received numerous funding awards from the National Science Foundation and the National Institutes of Health. In 2020, Walker was awarded the Carl Sagan Prize for Science Achievements. Walker’s research examines the impact of sleep on human health and disease. He has been featured on numerous podcasts (e.g., Andrew Huberman, Joe Rogan, Peter Attia), television and radio outlets, including CBS’ “60 Minutes,” National Geographic Channel, NOVA Science, NPR, and the BBC. He is also the host of the 5-star-rated podcast, The Matt Walker Podcast.

NYSE: EL
ELC-B


Contact details:

PR Contact: Tara Connaughton, [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTAN® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.